Valuation: Carvolix

Market Cap 41Cr 36Cr 34Cr 31Cr 58Cr 3.95TCr 59Cr 394.09Cr 154.41Cr 1.98TCr 155.55Cr 152.16Cr 6.6TCr P/E 2025 *
-13.7x
P/E 2026 * -13.1x
Enterprise Value 44Cr 38Cr 36Cr 33Cr 62Cr 4.22TCr 63Cr 420.54Cr 164.77Cr 2.11TCr 165.99Cr 162.37Cr 7.04TCr EV / Sales 2025
-
EV / Sales 2026 * 309x
Free-Float
25.49%
Yield 2025 *
-
Yield 2026 * -
1 day+1.32%
1 week+3.37%
Current month-4.06%
1 month-14.25%
3 months+103.31%
6 months+101.97%
Current year+254.91%
1 week 5.88
Extreme 5.88
6.66
1 month 4.95
Extreme 4.95
7.38
Current year 1.73
Extreme 1.73
7.56
1 year 1.32
Extreme 1.32
7.56
3 years 0.93
Extreme 0.93
7.56
5 years 0.93
Extreme 0.93
7.56
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap.
24/10/25
Truffle Capital SAS
BuyCompany 16,176 0.0411%
27/09/25
Truffle Capital SAS
BuyCompany 18,382 0.0467%
06/02/24
Truffle Capital SAS
BuyCompany 14,19,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%+3.37%+338.57%+458.18% 41Cr
+0.09%+0.64%+36.23%+31.86% 1.29TCr
-0.04%+0.29%+19.70%+26.78% 684.31Cr
+0.44%+7.59%+59.30%+38.72% 649.2Cr
+1.44%+4.16% - - 555.51Cr
+3.20%+0.81%-26.92%+50.94% 455.5Cr
-2.54%-3.45%-24.56%-18.78% 397.23Cr
+2.02%+8.54%+62.02%-43.47% 205.64Cr
+1.07%+5.08%+59.13%-5.43% 170.78Cr
-2.59%-11.43%-24.82%+115.10% 161.14Cr
Average +0.44%+753.67%+55.41%+72.66% 460.59Cr
Weighted average by Cap. +0.40%+769.93%+27.01%+31.56%

Financials

2025 2026 *
Net sales - 14.55L 12.61L 11.8L 10.77L 20.27L 14Cr 20.61L 1.38Cr 54.23L 6.95Cr 54.63L 53.44L 23Cr
Net income -2.21Cr -1.91Cr -1.79Cr -1.63Cr -3.08Cr -210.64Cr -3.13Cr -21Cr -8.23Cr -105.43Cr -8.29Cr -8.11Cr -351.73Cr -3.57Cr -3.09Cr -2.9Cr -2.64Cr -4.97Cr -340.54Cr -5.06Cr -34Cr -13Cr -170.45Cr -13Cr -13Cr -568.66Cr
Net Debt 2.78Cr 2.41Cr 2.26Cr 2.06Cr 3.87Cr 265.21Cr 3.94Cr 26Cr 10Cr 132.75Cr 10Cr 10Cr 442.86Cr 3.5Cr 3.03Cr 2.84Cr 2.59Cr 4.88Cr 333.89Cr 4.96Cr 33Cr 13Cr 167.12Cr 13Cr 13Cr 557.54Cr
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
76
Date Price Change Volume
12/26/12 6.140 +1.32% 5,496
11/26/11 €6.060 -0.33% 39,965
10/26/10 €6.080 -1.94% 11,689
07/26/07 €6.200 -1.90% 31,681
06/26/06 €6.320 +6.40% 66,687
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
6.060EUR
Average target price
8.775EUR
Spread / Average Target
+44.80%

Annual profits - Rate of surprise